生物技术

香港CK Life Sciences新子公司Sequencio Therapeutics正在推进约20个癌症疫苗项目，并计划明年在中国开展研究者发起试验，以加速人体试验进程。 CK Life Sciences副总裁兼首席科学官Melvin Toh Kean-meng博士表示，中国路径比传统监管流程更快，后者通常需一年半至两年才能给首位患者用药。

March 21, 2026 由 AI 报道

Researchers at Shandong University have modified the probiotic bacterium Escherichia coli Nissle 1917 to produce the anticancer drug Romidepsin directly in tumors. In mouse models of breast cancer, the engineered bacteria accumulated in tumors and released the drug. The findings were published on March 17 in PLOS Biology.

Scientists at EPFL have developed a technique called optovolution, using light to evolve proteins that switch states, sense environments, and perform computations. By engineering yeast cells to survive only if proteins behave dynamically, the method selects optimal variants rapidly. The approach, published in Cell, advances synthetic biology and optogenetics.

March 09, 2026 由 AI 报道

Researchers at the University of Helsinki have found that mitochondria in plant cells can draw oxygen away from chloroplasts, revealing a new interaction that affects photosynthesis and stress responses. This discovery, published in Plant Physiology, explains how plants manage internal oxygen levels. The study used genetically modified Arabidopsis thaliana plants to observe these processes.

ImmunityBio, Inc. conducted its full year 2025 earnings conference call on March 3, 2026, at 4:30 PM EST. The call featured company leaders and analysts, with a standard disclaimer on forward-looking statements. A replay is available on the company's investor relations website.

March 02, 2026 由 AI 报道

A team led by Leonardo Ferreira at the Medical University of South Carolina is developing a novel therapy combining lab-made insulin-producing cells with engineered immune cells to protect them. Funded by $1 million from Breakthrough T1D, the approach aims to restore beta cell function without immunosuppressive drugs. This strategy builds on prior research and targets all stages of the disease.